FDA Inspection 1064470 — New York Blood Center, Inc.

New York Blood Center, Inc. — FEI 1000143372

The FDA completed an inspection of New York Blood Center, Inc. on Aug 6, 2018 in Fishkill, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Aug 6, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Fishkill, NY (United States)